Waiting
Processando Login

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / CRISPR/Cas9 gebruiken om GM-CSF uit te nemen in…
JoVE Journal
Cancer Research

É necessário ter uma assinatura JoVE para assistir este Faça login ou comece sua avaliação gratuita.

JoVE Journal Cancer Research
CRISPR/Cas9 gebruiken om GM-CSF uit te nemen in CAR-T-cellen
 
Click here for the English version

CRISPR/Cas9 gebruiken om GM-CSF uit te nemen in CAR-T-cellen

Article DOI: 10.3791/59629-v • 07:56 min • July 22nd, 2019
July 22nd, 2019 •
1,2, 3, 3, 2,3
1Mayo Clinic Medical Scientist Training Program, Mayo Clinic College of Medicine and Science, 2Department of Immunology, Mayo Clinic, 3Division of Hematology, Mayo Clinic

Capítulos

Resumo
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Hier presenteren we een protocol voor genetisch gemodificeerde CAR-T cellen via een CRISPR/Cas9 systeem.

Tags

Kankeronderzoek probleem 149 chimerische antigeen receptor T cel CAR-T cel CRISPR/Cas9 genediting Knockout GM-CSF
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter